STOCK TITAN

FMR LLC discloses 5.7% stake in British American Tobacco (BTI) on Schedule 13G

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

British American Tobacco PLC reports institutional ownership disclosure by FMR LLC. FMR LLC beneficially owns 123,159,168.99 shares of Common Stock, representing 5.7% of the class as of 03/31/2026. The filing shows sole voting power of 109,894,891.63 and sole dispositive power of 123,159,168.99 attributed to FMR LLC and related reporting persons.

Positive

  • None.

Negative

  • None.

Insights

FMR LLC holds a 5.7% stake in British American Tobacco PLC, disclosed via Schedule 13G.

Schedule 13G indicates passive institutional ownership at the 5.7% threshold, with dispositive authority of 123,159,168.99 shares as of 03/31/2026. The filing lists sole voting power of 109,894,891.63, suggesting substantial control over voting in addition to disposition rights.

Ownership is reported on behalf of multiple entities under FMR's structure; Exhibit references note subsidiary classification and a 13d-1(k) agreement. Subsequent filings may clarify any changes in voting arrangements or shifts above reporting thresholds.

Beneficial ownership 123,159,168.99 shares Amount beneficially owned as of 03/31/2026
Percent of class 5.7% Percent of common stock reported
Sole voting power 109,894,891.63 shares Sole power to vote reported on cover page
Sole dispositive power 123,159,168.99 shares Sole power to dispose reported on cover page
Filing date reference 03/31/2026 Date tied to ownership figures
Schedule 13G regulatory
"Item 1. | (a) | Name of issuer: BRITISH AMERICAN TOBACCO PLC"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
Beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 123159168.99"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Dispositive power financial
"Item 4. | (iii) Sole power to dispose or to direct the disposition of: 123159168.99"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
13d-1(k) agreement regulatory
"Exhibit Information Please see Exhibit 99 for 13d-1(k) (1) agreement."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What stake does FMR LLC report in British American Tobacco (BTI)?

FMR LLC reports beneficial ownership of 123,159,168.99 shares, equal to 5.7% of the common stock as of 03/31/2026. The filing lists sole voting power of 109,894,891.63 and sole dispositive power of 123,159,168.99.

Does the Schedule 13G indicate FMR LLC is an active or passive holder?

The filing is a Schedule 13G, which typically indicates passive institutional ownership rather than an activist stake. The document does not state any intent to influence management or seek control actions.

Are any other persons shown as holding more than 5% of BTI in this filing?

The filing states that one or more other persons may have rights to dividends or sale proceeds, but it also discloses that no other person's interest exceeds 5% of the outstanding common stock.

Who signed the filing on behalf of FMR LLC and Abigail P. Johnson?

The filing is signed by Richard Bourgelas as duly authorized under a Power of Attorney effective April 13, 2026, on behalf of FMR LLC and on behalf of Abigail P. Johnson, with signature dates of 05/05/2026.

Is there any subsidiary or agreement referenced in the filing?

Yes, the filing references an attached Exhibit 99 for a 13d-1(k) agreement and notes an exhibit addressing the identification and classification of relevant subsidiaries that acquired the reported securities.





G1510J102

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



FMR LLC
Signature:Richard Bourgelas
Name/Title:Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of FMR LLC and its direct and indirect subsidiaries*
Date:05/05/2026
Abigail P. Johnson
Signature:Richard Bourgelas
Name/Title:Duly authorized under Power of Attorney effective as of April 13, 2026, by and on behalf of Abigail P. Johnson*
Date:05/05/2026

Comments accompanying signature: *This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on April 29,2026, accession number: 0000315066-26-000738.
Exhibit Information

Please see Exhibit 99 for 13d-1(k) (1) agreement.